Osteoporosis in men: Update 2011

Rheumatic Disease Clinics of North America

Volumn 37, Issue 3, 2011, Pages 401-414

  Orwig, Denise L ^a   Chiles, Nancy ^a   Jones, Mark ^a   Hochberg, Marc C ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Bone mineral density; Men; Osteoporosis; Screening; Treatment

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; DENOSUMAB; ESTRADIOL; PARATHYROID HORMONE[1-34]; RISEDRONIC ACID; TESTOSTERONE; VITAMIN D; ZOLEDRONIC ACID;

AGE; ANDROGEN DEPRIVATION THERAPY; BONE DENSITY; CORTICOSTEROID INDUCED OSTEOPOROSIS; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; ESTRADIOL BLOOD LEVEL; EXERCISE; FRAGILITY FRACTURE; HIGH RISK POPULATION; HIP FRACTURE; HUMAN; HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; INCIDENCE; LABORATORY TEST; LIFESTYLE MODIFICATION; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SCREENING TEST; SEX DIFFERENCE; SMOKING CESSATION; SUPPLEMENTATION; TESTOSTERONE BLOOD LEVEL; VERTEBRA FRACTURE; WRIST FRACTURE;

BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; FRACTURES, BONE; HUMANS; MALE; MEN'S HEALTH; OSTEOPOROSIS; PREVALENCE; RISK FACTORS;

EID: 82455205742     PISSN: 0889857X     EISSN: 15583163     Source Type: Journal    
DOI: 10.1016/j.rdc.2011.08.004     Document Type: Review

References (103)

1. Adler R.A. Osteoporosis in men: what has changed?. Curr Osteoporos Rep 2011, 9(1):31-35.
2. Khosla S. Update in male osteoporosis. J Clin Endocrinol Metab 2010, 95:3-10.
3. Ryan C., Petkov V.I., Adler R.A. Osteoporosis in men: the value of laboratory testing. Osteoporos Int 2011, 22(6):1845-1853.
4. Looker A.C., Melton L.J., Harris T.B., et al. Prevalence and trends in low femur bone density among older US adults: NHANES 2005-2006 compared with NHANES III. J Bone Miner Res 2010, 25:64-71.
5. Finkelstein J.S. Epidemiology and etiology of osteoporosis in men 2010, UpToDate, Available at:, Accessed December 28, 2010. http://www.uptodate.com.
6. Finkelstein J.S. Diagnosis and evaluation of osteoporosis in men 2010, UpToDate, Available at:, Accessed December 28, 2010. http://www.uptodate.com.
7. Finkelstein J.S. Treatment of osteoporosis in men 2010, UpToDate, Available at:, Accessed December 28, 2010. http://www.uptodate.com.
8. World Health Organization Assessment of fracture risk and application to screening for postmenopausal osteoporosis 1994, World Health Organization, Geneva (Switzerland).
9. National Osteoporosis Foundation. America's bone health: the state of osteoporosis and low bone mass. Available at: Accessed May 1, 2005. http://www.nof.org/advocacy/prevalence.
10. Dawson-Hughes B., Looker A.C., Tosteson N.A., et al. The potential impact of new National Osteoporosis Foundation guidance on treatment patterns. Osteoporos Int 2010, 21:41-52.
11. Berry S., Kiel D.P., Donaldson M.G., et al. Application of the National Osteoporosis Foundation Guidelines to postmenopausal women and men: the Framingham Osteoporosis Study. Osteoporos Int 2010, 21:53-60.
12. Morris C., Cabral D., Cheng H., et al. Patterns of bone mineral density testing: current guidelines, testing, rates, and interventions. J Gen Intern Med 2004, 19(7):783-790.
13. Centers for Medicare and Medicaid Services. Bone Mass Measurement: Overview. 2011. Available at: Accessed August 10, 2011. http://www.cms.gov/BoneMassMeasurement/.
14. Lane J., Serota A.C., Raphael B. Osteoporosis: differences and similarities in male and female patients. Orthop Clin North Am 2006, 37:601-609.
15. Nguyen N., Ahlborg H.G., Center J.R., et al. Residual lifetime risk of fractures in women and men. J Bone Miner Res 2007, 22(6):781-788.
16. Thomas-John M., Codd M.B., Manne S., et al. Risk factors for the development of osteoporosis and osteoporotic fractures among older men. J Rheumatol 2009, 36(9):1947-1952.
17. Burge R., Dawson-Hughes B., Solomon D.H., et al. Incidence and economic burden of osteoporosis-related fractures in the United States. J Bone Miner Res 2007, 22:465-475.
18. Ray N.F., Chan J.K., Thamer M., et al. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 1997, 12:24-35.
19. DeFrances CJ, Podgornik MN. 2004 National Hospital Discharge Survey: Annual Summary with detailed diagnosis and procedure data. Advance data from vital and health statistics. Hyattsville (MD): National Center for Health Statistics; 2006. Available at: Accessed August 10, 2011. http://www.cdc.gov/nchs/data/ad/ad371.pdf.
20. Melton L., Orwoll E., Wasnich R. Does bone density predict fractures comparably in men and women?. Osteoporos Int 2001, 12:707-709.
21. Chang K.P., Center J.R., Nguyen T.V., et al. Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res 2004, 19(4):532-536.
22. Haentjens P., Johnell O., Kanis J.A., et al. Evidence from data searches and life-table analyses for gender-related differences in absolute risk of hip fracture after Colles' or spine fracture: Colles' fracture as an early and sensitive marker of skeletal fragility in white men. J Bone Miner Res 2004, 19(12):1933-1944.
23. Melton L.J., Kearns A.E., Atkinson E.J., et al. Secular trends in hip fracture incidence and recurrence. Osteoporos Int 2008, 20(5):687-694.
24. Cummings S.R. BMD and risk of hip and nonvertebral fractures in older men: a prospective study and comparison with older women. J Bone Miner Res 2006, 21(10):1550.
25. Bass E., French D.D., Bradham D.D., et al. Risk-adjusted mortality rates of elderly veterans with hip fractures. Ann Epidemiol 2007, 17(7):514-519.
26. Endo Y., Aharonoff G.B., Zuckerman J.D., et al. Gender differences in patients with hip fracture: a greater risk of morbidity and mortality in men. J Orthop Trauma 2005, 19(1):29-35.
27. Penrod J., Litke A., Hawkes W.G., et al. The association of race, gender, and comorbidity with mortality and function after hip fracture. J Gerontol A Biol Sci Med Sci 2008, 63A(8):867-872.
28. Colon-Emeric C., Kuchibhatla M., Pieper C., et al. The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies. Osteoporos Int 2003, 14(11):879-883.
29. Bischoff H.A., Solomon D.H., Dawson-Hughes B., et al. Repeat hip fractures in a population-based sample of Medicare recipients in the US: timing and gender differences [abstract]. J Bone Miner Res 2001, 16(Suppl 1). S213.
30. Magaziner J., Lydick E., Hawkes W., et al. Excess mortality attributable to hip fracture in white women aged 70 years and older. Am J Public Health 1997, 87:1630-1636.
31. Hawkes W.G., Wehren L., Orwig D., et al. Gender differences in functioning after hip fracture. J Gerontol A Biol Sci Med Sci 2006, 61A(5):495-499.
32. Dennison E., Jameson K.A., Syddall H.E., et al. Bone health and deterioration in quality of life among participants from the Hertfordshire Cohort Study. Osteoporos Int 2010, 21(11):1817-1824.
33. Heaney R.P., Abrams S., Dawson-Hughes B., et al. Peak bone mass. Osteoporos Int 2000, 11:985-1009.
34. McGuigan F., Murray L., Gallagher A., et al. Genetic and environmental determinants of peak bone mass in young men and women. J Bone Miner Res 2002, 17(7):1273-1279.
35. Cummings S.R. Bone biology, epidemiology, and general principles. Osteoporosis: an Evidence-based Guide to Prevention and Management 2002, 3-25. American College of Physicians, Philadelphia (PA). S.R. Cummings, F. Cosman, S. Jamal (Eds.).
36. Seeman E., Delmas P.D. Bone quality - the material and structural basis of bone strength and fragility. New Engl J Med 2006, 354(21):2250-2261.
37. Hannan M.T., Felson D.T., Dawson-Hughes B., et al. Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res 2000, 15:710-720.
38. Amin S. Male osteoporosis: epidemiology and pathophysiology. Curr Osteoporos Rep 2003, 1:71-77.
39. Riggs B., Khosla S., Melton L.J. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 2002, 23(3):279-302.
40. Cauley J., Lui L.Y., Stone K.L., et al. Longitudinal study of changes in hip bone mineral density in Caucasian and African-American women. J Am Geriatr Soc 2005, 53(2):183-189.
41. Tracy J.K., Meyer W.A., Flores R.H., et al. Racial differences in rate of decline in bone mass in older men: the Baltimore Men's Osteoporosis Study. J Bone Miner Res 2005, 20(7):1228-1234.
42. Papaioannou A., Kennedy C.C., Cranney A., et al. Risk factors for low BMD in healthy men age 50 years or older: a systematic review. Osteoporos Int 2009, 20(4):507-518.
43. Naves M., Diaz-Lopez J.G., Gomez C., et al. Prevalence of osteoporosis in men and determinants of changes in bone mass in a non-selected Spanish population. Osteoporos Int 2005, 16:603-609.
44. Bakhireva L., Barrett-Connonr E., Kritz-Silverstein D., et al. Modifiable predictors of bone loss in older men: a prospective study. Am J Prev Med 2004, 26(5):436-442.
45. Scholtissen S., Guillemin F., Bruyere O., et al. Assessment of determinants for osteoporosis in elderly men. Osteoporos Int 2009, 20:1157-1166.
46. Lewis C. Predictors of non-spine fracture in elderly men: the MrOS Study. J Bone Miner Res 2007, 22(2):211.
47. Greenspan S., Coates P., Sereika S.M., et al. Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer. J Clin Endocrinol Metab 2005, 90(12):6410-6417.
48. Campion J, Maricic MJ. Osteoporosis in men. 2003. Available at: Accessed August 10, 2011. http://www.aafp.org/afp/2003/0401/p1521.html.
49. Meier C., Nguyen T.V., Handelsman D.J., et al. Endogenous sex hormones and incident fracture risk in older men. The Dubbo Osteoporosis Epidemiology Study. Arch Intern Med 2008, 168(1):47-54.
50. Falahati-Nini A., Riggs B.L., Atkinson E.J., et al. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 2000, 106:1553-1560.
51. Venken K., Callewaert F., Boonen S., et al. Sex hormones, their receptors, and bone health. Osteoporos Int 2008, 19(11):1517-1525.
52. Amin S., Zhang Y., Felson D.T., et al. Estradiol, testosterone, and the risk for hip fracture in elderly men from the Framingham Study. Am J Med 2006, 119:426-433.
53. LeBlanc E., Nielson C.M., Marshall L.M., et al. The effects of serum testosterone, estradiol, and sex hormone binding globulin levels on fracture risk in older men. J Clin Endocrinol Metab 2009, 94:3337-3346.
54. George A., Tracy J.K., Meyer W.A., et al. Racial differences in bone mineral density in older men. J Bone Miner Res 2003, 18(12):2238-2244.
55. Chiu G., Araujo A.B., Travison T.G., et al. Relative contributions of multiple determinants to bone mineral density in men. Osteoporos Int 2009, 20:2035-2047.
56. Baim S., Binkley N., Bilezikian J.P., et al. Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference. J Clin Densitom 2008, 11(1):75-91.
57. Qaseem A., Snow V., Shekelle P., et al. Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Screening for osteoporosis in men: a clinical practice guideline Screening for osteoporosis in men: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2008, 148(9):680-684.
58. Shekelle P, Munjas B, Liu H, et al. Screening men for osteoporosis: who & how. Available at: Accessed August 9, 2011. http://www.ncbi.nlm.nih.gov/books/NBK49063/.
59. Liu H., Paige N.M., Goldzweig C.L., et al. Screening for osteoporosis in men: a systematic review for an American College of Physicians Guideline. Ann Intern Med 2008, 148(9):685-701.
60. Nelson HD, Haney EM, Chou R, et al. Screening for osteoporosis: Systematic Review to Update the 2002 U.S. Preventive Services Task Force Recommendation. 2010. Available at: Accessed August 9, 2011. http://www.ncbi.nlm.nih.gov/books/NBK45201/.
61. Department of Veterans Affairs VHA. 2009. Available at: Accessed August 9, 2011. http://www.va.gov/vhapublications/ViewPublication.asp?pub_ID=2083.
62. Petzel R.A. Undersecretary for Health's Information Letter. Osteoporosis in Men 2011, Department of Veterans Affairs, Veterans Health Administration, Washington, DC.
63. Vermeulen A., Kaufman J.M. Ageing of the hypothalamo-pituitary-testicular axis in men. Horm Res 1995, 43(1-3):25-28.
64. Faiman C. Male Hypogonadism. 2009. Available at: Accessed August 9, 2011. http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/male-hypogonadism/.
65. Finkelstein J., Klibanski A., Neer R.M., et al. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med 1987, 106(3):354-361.
66. Stoch S., Parker R.A., Chen L., et al. Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists. J Clin Endocrinol Metab 2001, 86(6):2787-2791.
67. Diamond T., Stiel D., Posen S. Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors?. Ann Intern Med 1989, 110(6):430-436.
68. Katznelson L., Finkelstein J.S., Schoenfeld D.A., et al. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab 1996, 81:4358-4365.
69. Behre H., Kliesch S., Leifke E., et al. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 1997, 82(8):2386-2390.
70. Finkelstein J., Klibanski A., Neer R.M., et al. Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1989, 69(4):776-783.
71. Abbasi A., Rudman D., Wilson C.R., et al. Observations on nursing home residents with a history of hip fracture. Am J Med Sci 1995, 310(6):229-234.
72. Scane A., Sutcliffe A.M., Francis R.M. Osteoporosis in men. Bailliere's Clin Rheumatol 1993, 7:589-601.
73. Guo C., Jones T.H., Eastell R. Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover. J Clin Endocrinol Metab 1997, 82(2):658-665.
74. Finkelstein J., Neer R.M., Biller B.M., et al. Osteopenia in men with a history of delayed puberty. N Engl J Med 1992, 326(9):600-604.
75. Finkelstein J., Klibanski A., Neer R.M. A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty. J Clin Endocrinol Metab 1996, 81(3):1152-1155.
76. Bertelloni S., Baroncelli G.I., Battini R., et al. Short-term effect of testosterone treatment on reduced bone density in boys with constitutional delay of puberty. J Bone Miner Res 1995, 10(10):1488-1495.
77. Araujo A.B., Travison T.G., Harris S.S., et al. Race/ethnic differences in bone mineral density in men. Osteoporos Int 2007, 18(7):943-953.
78. Slemenda C., Longcope C., Zhou L., et al. Sex steroids and bone mass in older men: positive associations with serum estrogens and negative associations with androgens. J Clin Invest 1997, 100:1755-1759.
79. Khosla S., Melton L.J., Atkinson E.J., et al. Relationship of serum sex steroid levels and bone turnover markers with bone mineral denstiy in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab 1998, 83(7):2266-2274.
80. Ongphiphadhanakul B., Rajatanavin R., Chanprasertyothin S., et al. Serum oestradiol and oestrogen-receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males. Clin Endocrinol 1998, 49:803-809.
81. Center J., Nguyen T.V., Sambrook P.N., et al. Hormonal and biochemical parameters in the determination of osteoporosis in elderly men. J Clin Endocrinol Metab 1999, 84(10):3626-3635.
82. Greendale G., Edelstein S., Barrett-Connor E. Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study. J Bone Miner Res 1997, 12(11):1833-1843.
83. Amin S., Zhang Y., Sawin C.T., et al. Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham Study. Ann Intern Med 2000, 133(12):951-963.
84. Araujo A., Travison T.G., Leder B.Z., et al. Correlations between serum testosterone, estradiol, and sex hormone-binding globulin and bone mineral density in a diverse sample of men. J Clin Endocrinol Metab 2008, 93(6):2135-2141.
85. Meier D., Orwoll E.S., Keenan E.J., et al. Marked decline in trabecular bone mineral content in healthy men with age: lack of association with sex steroid levels. J Am Geriatr Soc 1987, 35(3):189-197.
86. Rudman D., Drinka P.J., Wilson C.R., et al. Relations of endogenous anabolic hormones and physical activity to bone mineral density and lean body mass in elderly men. Clin Endocrinol 1994, 40(5):653-661.
87. Fink H., Ewing S.K., Ensrud K.E., et al. Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men. J Clin Endocrinol Metab 2006, 91(10):3908-3915.
88. Mellstrom D., Johnell O., Ljunggren O., et al. Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J Bone Miner Res 2006, 21(4):529-535.
89. Ensrud K., Lewis C.E., Lambert L.C., et al. Osteoporotic Fractures in Men MrOS Study Research Group. Endogenous sex steroids, weight change and rates of hip bone loss in older men: the MrOS study. Osteoporos Int 2006, 17(9):1329-1336.
90. Nayak S, Liu H, Michaud K, et al. Cost-effectivess of alternative screening strategies for osteoporosis in postmenopausal women. 2006; Available at: Accessed August 10, 2011. http://smdm.confex.com.
91. Schousboe J., Ensrud K.E., Nyman J.A., et al. Universal bone densitometry, screening combined with alendronate therapy for those diagnosed with osteoporosis in highly cost-effective for elderly women. J Am Geriatr Soc 2005, 53(10):1697-1704.
92. Schousboe J., Taylor B.C., Fink H.A., et al. Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. JAMA 2007, 298(6):629-637.
93. Bolland M., Grey A.B., Gamble G.D., et al. Effect of osteoporosis treatment on mortality: a meta-analysis. J Clin Endocrinol Metab 2010, 95(3):1174-1181.
94. National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis. 2008. Available at: 2011. Accessed August 10, 2011. http://www.nof.org/sites/default/files/pdfs/NOF_Clinicians_Guide2008.pdf.
95. Curtis J., Adachi J.D., Saag K.G. Bridging the osteoporosis quality chasm. J Bone Miner Res 2009, 24:3-7.
96. Papaioannou A., Kennedy C.C., Loannidis G., et al. The osteoporosis care gap in men with fragility fractures: the Canadian Multicenter Osteoporosis Study. Osteoporos Int 2008, 19:581-587.
97. Kiebzak G.M., Beinart G.A., Perser K., et al. Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med 2002, 162(19):2217-2222.
98. Force AHT. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients - 2002 update. 2002. Available at: Accessed August 10, 2011. http://www.touchgroupplc.com/pdf/790/2-aacehtf.pdf.
99. Arisaka O., Arisaka M., Nakayama Y., et al. Effect of testosterone on bone density and bone metabolism in adolescent male hypogonadism. Metabolism 1995, 44:419-423.
100. van der Werff ten Bosch J.J., Bot A. Some skeletal dimensions of males with isolated gonadotrophin deficiency. Neth J Med 1992, 41:259-263.
101. Adler R.A., Hochberg M.C. Glucocorticoid-induced osteoporosis in men. Endocrinol Invest 2011, 34:481-484.
102. Grossman J.M., Gordon R., Ranganath V.K., et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken) 2010, 62(11):1515-1526.
103. Reid I.R., Wattie D.J., Evans M.C., et al. Testosterone therapy in glucocorticoid-treated men. Arch Intern Med 1996, 15:1173-1177.